DreaMed Diabetes
Latest round
- Series B
Last raised
- Aug 2024
Total raised
- $3M
Investors
- 1
About DreaMed Diabetes
Based in Petah Tikva, Israel, and founded in 2014 by Chief Executive Officer Eran Atlas and co-founder Ido Mueller, DreaMed Diabetes, Ltd. operates as a health tech company developing solutions for treating diabetes that utilizes event-driven machine learning and logic technologies. In August 2024, DreaMed Diabetes, Ltd. DreaMed Diabetes, Ltd. focuses on creating diabetes management through artificial intelligence (AI). The company developed a product known as Endo. Digital, which is a cloud-based platform that supports healthcare providers by offering AI-powered treatment recommendations for both Type 1 and Type 2 diabetes. Its system integrates with electronic medical records (EMR), automates billing documentation, and engages patients through a mobile app. In addition, the firm leverages technology-based tools for a decision support system that utilizes data from CGM/SMBG (continuous glucose monitoring/self-monitoring of blood glucose) and insulin pumps., advance its platform, and grow the team. The funds will support scaling efforts, enhance technology, and drive new partnerships, including recent agreements with Abbott and Yale New Haven Health.
Who invested in DreaMed Diabetes
1 investor across 1 round
See all investors in DreaMed Diabetes
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Aug 19, 2024
Amount
$3M
Investors
Questions about DreaMed Diabetes
Who invested in DreaMed Diabetes?
DreaMed Diabetes has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has DreaMed Diabetes raised?
DreaMed Diabetes has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did DreaMed Diabetes last raise money?
DreaMed Diabetes's most recent round on record is a Series B, in Aug 2024.
What does DreaMed Diabetes do?
Based in Petah Tikva, Israel, and founded in 2014 by Chief Executive Officer Eran Atlas and co-founder Ido Mueller, DreaMed Diabetes, Ltd.
Where is DreaMed Diabetes headquartered?
DreaMed Diabetes is headquartered in Petah Tikva, Israel.
Which VCs invest in companies like DreaMed Diabetes?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back medical devices & equipment companies at DreaMed Diabetes's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like DreaMed Diabetes? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.